Uncategorized
Biotechnology / Science

From the front lines of the CRISPR debate

An event at Genspace explored the ethics of gene editing.

At Genspace, people can get hands-on with DNA. (Courtesy image)

In dystopian visions of the future, genetic engineering often plays a part in our demise. Think Gattaca. Or the novel A Brave New World. Or Bladerunner.

But if what it’s not all so bad? What if genetic engineering could eliminate Malaria? Or allow farmers to grow healthy crops without chemicals. Thanks a new advancement in gene editing technology, CRISPR, this future may be within reach soon.

Last Friday night at Genspace’s new industrial-looking lab, I went to a talk about CRISPR. It was led by the director of a new documentary on the topic, Adam Bolt, who’s been researching the technology for the last year. Bolt praised the science and the all the scientists working on it as pioneers of a biological revolution. CRISPR allows scientists to ask new questions: which genes matter, and why?

Director Adam Bolt talks CRISPR at his talk Thursday night at Genspace.

Director Adam Bolt talks CRISPR at his talk Thursday night at Genspace. (Photo by Lucas Manfield)

Bolt used the analogy of a switchboard. Each gene isolated by CRISPR becomes a switch that scientists can flick to test its effects. With enough flicks, they hope to isolate the genes that control genetic disease, tomato tastiness, and maybe even eye color.

Dylan Williams, 26, was impressed. He works in pharmaceuticals and came to the event out of interest in the topic. It’s “an amazing step forward,” he said, there’s “so many terrible inherited diseases that CRISPR could solve.”

But what about those dystopias?

“There’s good reason it should be approached with caution, but I hate the slippery slope argument,” said Jeff Aalberg, 25, who made the trek to Sunset Park all the way from Manhattan. As it is now, there’s “a lottery system for quality of life” he noted. “Any opportunity should be taken to solve it.”

Alex Pound, a 54-year-old software engineer living in Brooklyn, wasn’t as optimistic. “One thing not covered [in the talk] was the negative side. What if you mutate the flu? Certainly there are people out there who want to do that and could turn it loose.”

As we chatted, I couldn’t help but peek over into the gleaming lab. Genspace describes itself on its website as “a place where anyone can learn and work on biotechnology.” They offer four-day “Biohacker Bootcamps,” in which students can “learn all the standard techniques” of gene editing.

While conceptually appealing, the democratization of genetic engineering has consequences that, on reflection, become viscerally terrifying.

As Bolt noted, wistfully, it’s easy to liken CRISPR to Pandora’s box. But, he points out, what technology doesn’t have the possibility for unforeseen consequences? And, unlike nuclear weapons, eugenics and other morally repugnant technologies, CRISPR wasn’t born in a government lab or corporate headquarters. It’s the result of the work of hundreds of scientists, romanticized by Bolt as “just trying to understand how life works.”

It’s easy, however, to overstate CRISPR’s power. Elliot Kirschner, Bolt’s fellow producer, offers a note of caution.

“There’s [a significant] distance between what is written in DNA and your traits. It’s not clear when and how we figure that out,” he said.

Although it wasn’t emphasized in Bolt’s talk, nearly everyone I talked to afterword mentioned the importance of government regulation. Obtaining the chemicals required to perform gene editing is a highly regulated process, and the National Academy of Sciences only recently approved limited government funding of CRISPR research.

“Why,” Bolt asked, “can we not, as a society, figure out how to have the good and not the bad? Where do we set the line?”

I asked Dan Grushkin, cofounder and executive director of Genspace, about the lab’s role in the conversation. “I see us at the forefront,” he said. “[We’re] reaching out to the public. We will inform the debate. This is what you can do with [CRISPR] and here are the social implications.” He gestured at the room around us and added. “We’re very much a community lab. Conversations happen one on one.”

Personally, apprehensions about CRISPR aside, I’m heartened by the notion of innovation happening here in the open rather than behind locked doors at Monsanto’s labs. Thanks to Genspace, you can get hands-on experience with CRISPR and see it for yourself. The next bootcamp starts Oct. 23.

Companies: Genspace
Series: Brooklyn

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

Get a snapshot of Baltimore's latest housing, job and business trends with this new easy-access tool

Technically Media